CPEB2 Suppresses Hepatocellular Carcinoma Epithelial–Mesenchymal Transition and Metastasis through Regulating the HIF-1α/miR-210-3p/CPEB2 Axis

Hepatocellular carcinoma (HCC) is a prevalent and high-mortality cancer worldwide, and its complexity necessitates novel strategies for drug selection and design. Current approaches primarily focus on reducing gene expression, while promoting gene overexpression remains a challenge. In this work, we...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Ran, Yang, Yanjun, Yin, Guowen, Jiang, Hao, Lu, Yousheng, Gui, Liang, Bao, Jun, Xu, Qingyu, Feng, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386397/
https://www.ncbi.nlm.nih.gov/pubmed/37514073
http://dx.doi.org/10.3390/pharmaceutics15071887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10386397/
https://www.ncbi.nlm.nih.gov/pubmed/37514073
http://dx.doi.org/10.3390/pharmaceutics15071887

Ejemplares similares